About N-[4-[(2R)-4-methyl-2-phenylpiperazine-1-carbonyl]-3-[(3R)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl]cyclopropanecarboxamide;hydrochloride
N-[4-[(2R)-4-methyl-2-phenylpiperazine-1-carbonyl]-3-[(3R)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl]cyclopropanecarboxamide;hydrochloride (PubChem CID 175861894) has the molecular formula C27H32ClF3N4O2
and a molecular weight of 537.03 g/mol. Its IUPAC name is N-[4-[(2R)-4-methyl-2-phenylpiperazine-1-carbonyl]-3-[(3R)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl]cyclopropanecarboxamide;hydrochloride.
Molecular Properties
| Compound Name | N-[4-[(2R)-4-methyl-2-phenylpiperazine-1-carbonyl]-3-[(3R)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl]cyclopropanecarboxamide;hydrochloride |
| PubChem CID | 175861894 |
| Molecular Formula | C27H32ClF3N4O2 |
| Molecular Weight | 537.03 g/mol |
| Exact Mass | 536.22 |
| IUPAC Name | N-[4-[(2R)-4-methyl-2-phenylpiperazine-1-carbonyl]-3-[(3R)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl]cyclopropanecarboxamide;hydrochloride |
| SMILES | CN1CCN(C(=O)c2ccc(NC(=O)C3CC3)cc2N2CC[C@@H](C(F)(F)F)C2)[C@H](c2ccccc2)C1.Cl |
| InChI | InChI=1S/C27H31F3N4O2.ClH/c1-32-13-14-34(24(17-32)18-5-3-2-4-6-18)26(36)22-10-9-21(31-25(35)19-7-8-19)15-23(22)33-12-11-20(16-33)27(28,29)30;/h2-6,9-10,15,19-20,24H,7-8,11-14,16-17H2,1H3,(H,31,35);1H/t20-,24+;/m1./s1 |
| InChIKey | LOVFUHKVGLMZNG-UFZJIDKFSA-N |
| XLogP | 4.97 |
| TPSA | 55.89 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 537.03 |
| LogP ≤ 5 | 4.97 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Analyze N-[4-[(2R)-4-methyl-2-phenylpiperazine-1-carbonyl]-3-[(3R)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl]cyclopropanecarboxamide;hydrochloride with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[4-[(2R)-4-methyl-2-phenylpiperazine-1-carbonyl]-3-[(3R)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl]cyclopropanecarboxamide;hydrochloride?
The IUPAC name of N-[4-[(2R)-4-methyl-2-phenylpiperazine-1-carbonyl]-3-[(3R)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl]cyclopropanecarboxamide;hydrochloride (CID 175861894) is N-[4-[(2R)-4-methyl-2-phenylpiperazine-1-carbonyl]-3-[(3R)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl]cyclopropanecarboxamide;hydrochloride.
What is the SMILES notation for N-[4-[(2R)-4-methyl-2-phenylpiperazine-1-carbonyl]-3-[(3R)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl]cyclopropanecarboxamide;hydrochloride?
The canonical SMILES for N-[4-[(2R)-4-methyl-2-phenylpiperazine-1-carbonyl]-3-[(3R)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl]cyclopropanecarboxamide;hydrochloride is CN1CCN(C(=O)c2ccc(NC(=O)C3CC3)cc2N2CC[C@@H](C(F)(F)F)C2)[C@H](c2ccccc2)C1.Cl.
What is the InChIKey of N-[4-[(2R)-4-methyl-2-phenylpiperazine-1-carbonyl]-3-[(3R)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl]cyclopropanecarboxamide;hydrochloride?
The InChIKey is LOVFUHKVGLMZNG-UFZJIDKFSA-N. The full InChI is InChI=1S/C27H31F3N4O2.ClH/c1-32-13-14-34(24(17-32)18-5-3-2-4-6-18)26(36)22-10-9-21(31-25(35)19-7-8-19)15-23(22)33-12-11-20(16-33)27(28,29)30;/h2-6,9-10,15,19-20,24H,7-8,11-14,16-17H2,1H3,(H,31,35);1H/t20-,24+;/m1./s1.
What are the key properties of N-[4-[(2R)-4-methyl-2-phenylpiperazine-1-carbonyl]-3-[(3R)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl]cyclopropanecarboxamide;hydrochloride?
N-[4-[(2R)-4-methyl-2-phenylpiperazine-1-carbonyl]-3-[(3R)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl]cyclopropanecarboxamide;hydrochloride has a molecular weight of 537.03 g/mol, XLogP of 4.97, 5 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[(2R)-4-methyl-2-phenylpiperazine-1-carbonyl]-3-[(3R)-3-(trifluoromethyl)pyrrolidin-1-yl]phenyl]cyclopropanecarboxamide;hydrochloride is sourced from PubChem (CID 175861894), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).